Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

Biogen’s effort to buy Sage against the board’s wishes and a long-time effort by investor Alcorn to scuttle Aurion’s IPO ...

Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Lasell University president Eric Turner is hoping that many Lasell students will find success in the real world by spending ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...

While consumer spending is high, so is business investment, according to  Deloitte  ? which can make differentiating amongst competitors harder than ever with significant gains or losses at ...

Biogen Inc. is fending off a lawsuit in the Delaware Chancery Court over its recent offer to buy out Sage Therapeutics, its ...

RFK Jr. faces unified opposition for HHS post; Trump disrupts NIH proceedings; Biogen CEO tells Mass. Gov there is “policy ...

Listed Tyneside pharmaceutical firm Shield Therapeutics has appointed a new CEO. The Gateshead drug discovery business, which ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...